{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,6]],"date-time":"2026-04-06T11:37:58Z","timestamp":1775475478778,"version":"3.50.1"},"reference-count":36,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100008605","name":"Indian National Science Academy","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008605","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001501","name":"University Grants Commission","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001501","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Parasitology International"],"published-print":{"date-parts":[[2021,6]]},"DOI":"10.1016\/j.parint.2021.102287","type":"journal-article","created":{"date-parts":[[2021,1,27]],"date-time":"2021-01-27T11:49:03Z","timestamp":1611748143000},"page":"102287","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"special_numbering":"C","title":["The HIV\u00a0\u2212\u00a01 protease inhibitor Amprenavir targets Leishmania donovani topoisomerase I and induces oxidative stress-mediated programmed cell death"],"prefix":"10.1016","volume":"82","author":[{"given":"Amit","family":"Roy","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sachidananda","family":"Behera","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Priyanka H.","family":"Mazire","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bhavini","family":"Kumari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abhishek","family":"Mandal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bidyut","family":"Purkait","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Payel","family":"Ghosh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Prolay","family":"Das","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pradeep","family":"Das","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.parint.2021.102287_bb0005","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1136\/bmj.296.6636.1557","article-title":"Rationalization of regimens of treatment of kala-azar with sodium stibogluconate in India: a randomised study","volume":"296","author":"Thakur","year":"1988","journal-title":"Br. Med. J."},{"issue":"Suppl. 1","key":"10.1016\/j.parint.2021.102287_bb0010","doi-asserted-by":"crossref","first-page":"S17","DOI":"10.1016\/j.trstmh.2006.02.010","article-title":"Development of miltefosine as an oral treatment for leishmaniasis","volume":"100","author":"Sindermann","year":"2006","journal-title":"Trans. R. Soc. Trop. Med. Hyg."},{"key":"10.1016\/j.parint.2021.102287_bb0015","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1016\/0140-6736(92)92952-C","article-title":"Amphotericin versus pentamidine in antimony-unresponsive kala-azar","volume":"340","author":"Mishra","year":"1992","journal-title":"Lancet."},{"key":"10.1016\/j.parint.2021.102287_bb0020","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.4269\/ajtmh.2010.10-0171","article-title":"Lipsosomal amphotericin B for treatment of cutaneous leishmaniasis","volume":"83","author":"Wortmann","year":"2010","journal-title":"Am J Trop Med Hyg."},{"key":"10.1016\/j.parint.2021.102287_bb0025","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1111\/j.1468-3083.2010.03908.x","article-title":"Liposomal amphotericin B treatment of cutaneous leishmaniasis due to Leishmania tropica","volume":"25","author":"Solomon","year":"2011","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"issue":"2","key":"10.1016\/j.parint.2021.102287_bb0030","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/0169-4758(94)90398-0","article-title":"Medicinal plants in the fight against leishmaniasis","volume":"10","author":"Iwu","year":"1994","journal-title":"Parasitol. Today"},{"key":"10.1016\/j.parint.2021.102287_bb0035","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1042\/BJ20071286","article-title":"An insight into the mechanism of inhibition of unusual bi-subunit topoisomerase I from Leishmania donovani by 3,3\u2032-di-indolylmethane, a novel DNA topoisomerase I poison with a strong binding affinity to the enzyme","volume":"409","author":"Roy","year":"2008","journal-title":"Biochem. J."},{"key":"10.1016\/j.parint.2021.102287_bb0040","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/S0006-291X(88)80081-0","article-title":"Mode of action of pentavalent antimonials: specific inhibition of type I DNA topoisomerase of Leishmania donovani","volume":"152","author":"Chakraborty","year":"1988","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.parint.2021.102287_bb0045","doi-asserted-by":"crossref","first-page":"3726","DOI":"10.1073\/pnas.92.9.3726","article-title":"Molecular and cytotoxic effects of camptothecin, a topoisomerase I inhibitor, on trypanosomes and Leishmania","volume":"92","author":"Bodley","year":"1995","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.parint.2021.102287_bb0050","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/0169-4758(96)10017-X","article-title":"Topoisomerases in kinetoplastids","volume":"12","author":"Burri","year":"1996","journal-title":"Parasitol. Today"},{"key":"10.1016\/j.parint.2021.102287_bb0055","first-page":"81","article-title":"Reconstitution and functional characterization of the unusual bi-subunit type I DNA topoisomerase from Leishmania donovani","volume":"565","author":"Das","year":"2004","journal-title":"FEBS Lett."},{"key":"10.1016\/j.parint.2021.102287_bb0060","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/j.exppara.2010.06.002","article-title":"Effects of HIV aspartyl-proteinase inhibitors on Leishmania sp","volume":"126","author":"Valdivieso","year":"2010","journal-title":"Exp. Parasitol."},{"key":"10.1016\/j.parint.2021.102287_bb0065","first-page":"407","article-title":"Diagnosis & management of leishmaniasis\/ HIV co-infection","volume":"121","author":"Sinha","year":"2005","journal-title":"Indian J. Med. Res."},{"issue":"2","key":"10.1016\/j.parint.2021.102287_bb0070","first-page":"62","article-title":"Epidemiology of visceral leishmaniasis in India","volume":"12","author":"Bora","year":"1999","journal-title":"Natl Med. J. India"},{"key":"10.1016\/j.parint.2021.102287_bb0075","doi-asserted-by":"crossref","first-page":"e35671","DOI":"10.1371\/journal.pone.0035671","article-title":"Leishmaniasis worldwide and global estimates of its incidence","volume":"7","author":"Alvar","year":"2012","journal-title":"PLoS One"},{"issue":"7","key":"10.1016\/j.parint.2021.102287_bb0080","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1099\/jmm.0.46574-0","article-title":"Visceral leishmaniasis\/ human immunodeficiency virus co-infection in India: the focus of two epidemics","volume":"55","author":"Mathur","year":"2006","journal-title":"J. Med. Microbiol."},{"key":"10.1016\/j.parint.2021.102287_bb0085","doi-asserted-by":"crossref","first-page":"40","DOI":"10.2174\/1874104501105010040","article-title":"HIV protease inhibitors: effect on the opportunistic protozoan parasites","volume":"5","author":"Yenisey","year":"2011","journal-title":"Open Medicinal Chem. J."},{"issue":"3","key":"10.1016\/j.parint.2021.102287_bb0090","doi-asserted-by":"crossref","first-page":"e4918","DOI":"10.1371\/journal.pone.0004918","article-title":"HIV Aspartyl peptidase inhibitors interfere with cellular proliferation, ultrastructure and macrophage infection of Leishmania amazonensis","volume":"4","author":"Santos","year":"2009","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.parint.2021.102287_bb0095","doi-asserted-by":"crossref","first-page":"e642","DOI":"10.1371\/journal.pntd.0000642","article-title":"Nelfinavir, an HIV-1 protease inhibitor, induces oxidative stress\u2013mediated, Caspase-independent apoptosis in Leishmania Amastigotes","volume":"4","author":"Pranav Kumar","year":"2010","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.parint.2021.102287_bb0100","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/S0149-2918(00)80044-2","article-title":"Amprenavir: a new human immunodeficiency virus type 1 protease inhibitor","volume":"22","author":"Fung","year":"2000","journal-title":"Clin. Ther."},{"key":"10.1016\/j.parint.2021.102287_bb0105","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.2165\/00003495-200060060-00012","article-title":"Amprenavir: a review of its clinical potential in patients with HIV infection","volume":"60","author":"Noble","year":"2000","journal-title":"Drugs."},{"issue":"5","key":"10.1016\/j.parint.2021.102287_bb0110","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1124\/mol.108.050161","article-title":"Mitochondria dependent ROS-mediated programmed cell death (PCD) induced by 3,3\u2032-diindolylmethane (DIM) through inhibition of FoF1-ATP synthase in unicellular protozoan parasite Leishmania donovani","volume":"74","author":"Roy","year":"2008","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.parint.2021.102287_bb0115","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.exppara.2017.02.010","article-title":"Copper salisylaldoxime (CuSAL) imparts protective efficacy against visceral leishmaniasis by targeting Leishmania donovani topoisomerase IB","volume":"175","author":"Singh","year":"2017","journal-title":"Exp. Parasitol."},{"issue":"5","key":"10.1016\/j.parint.2021.102287_bb0120","doi-asserted-by":"crossref","first-page":"3332","DOI":"10.1529\/biophysj.105.067223","article-title":"Dissecting homo-heptamer thermodynamics by isothermal titration calorimetry: entropy-driven assembly of co-chaperonin protein 10","volume":"89","author":"Luke","year":"2005","journal-title":"Biophys. J."},{"issue":"2","key":"10.1016\/j.parint.2021.102287_bb0125","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1002\/jcc.21334","article-title":"AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading","volume":"31","author":"Trott","year":"2010","journal-title":"J. Comput. Chem."},{"key":"10.1016\/j.parint.2021.102287_bb0130","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1007\/BF03402104","article-title":"Dihydrobetulinic acid induces apoptosis in Leishmania donovani by targeting DNA topoisomerase I and II: implications in anti-leishmanial therapy","volume":"9","author":"Chowdhury","year":"2003","journal-title":"Mol. Med."},{"key":"10.1016\/j.parint.2021.102287_bb0135","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1038\/sj.cdd.4401435","article-title":"Camptothecin induced mitochondrial dysfunction leading to programmed cell death in unicellular hemoflagellate Leishmania donovani","volume":"11","author":"Sen","year":"2004","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.parint.2021.102287_bb0140","first-page":"869","article-title":"The mtDNA T8993G (NARP) mutation results in an impairment of oxidative phosphorylation that can be improved by antioxidants","volume":"13","author":"Mattiazzi","year":"2004","journal-title":"Hum MolGenet."},{"key":"10.1016\/j.parint.2021.102287_bb0145","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1007\/BF00048058","article-title":"A biochemical hallmark of apoptosis: internucleosomal degradation of the genome","volume":"11","author":"Compton","year":"1992","journal-title":"Cancer Metastasis Rev."},{"key":"10.1016\/j.parint.2021.102287_bb0150","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1128\/CMR.00061-07","article-title":"The relationship between leishmaniasis and AIDS: the second 10 years","volume":"21","author":"Alvar","year":"2008","journal-title":"Clin. Microbiol. Rev."},{"key":"10.1016\/j.parint.2021.102287_bb0155","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1179\/000349803225002499","article-title":"Leishmania\/HIV co-infections: epidemiology in Europe","volume":"97","author":"Desjeux","year":"2003","journal-title":"Ann. Trop. Med. Parasitol."},{"key":"10.1016\/j.parint.2021.102287_bb0160","doi-asserted-by":"crossref","first-page":"1702","DOI":"10.1086\/587899","article-title":"Concordant HIV infection and visceral leishmaniasis in Ethiopia: the influence of antiretroviral treatment and other factors on outcome","volume":"46","author":"ter Horst","year":"2008","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.parint.2021.102287_bb0165","first-page":"11","article-title":"Dual role of glutathione in modulating camptothecin activity: depletion potentiates activity, but conjugation enhances the stability of the topoisomerase I-DNA cleavage complex","volume":"1","author":"Gamcsik","year":"2001","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.parint.2021.102287_bb0170","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/S0891-5849(99)00083-0","article-title":"Cupric nitrilotriacetate-induced apoptosis in HL-60 cells association with lipid peroxidation, release of cytochrome C from mitochondria, and activation of caspase-3","volume":"27","author":"Ma","year":"1999","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.parint.2021.102287_bb0175","doi-asserted-by":"crossref","first-page":"6027","DOI":"10.1093\/emboj\/18.21.6027","article-title":"von Harsdorf R. p53 regulates mitochondrial membrane potential through reactive oxygen species and induces cytochrome c-independent apoptosis blocked by Bcl-2","volume":"18","author":"Li","year":"1999","journal-title":"EMBO J."},{"key":"10.1016\/j.parint.2021.102287_bb0180","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1038\/sj.cdd.4400952","article-title":"Programmed cell death in the unicellular protozoan parasite Leishmania","volume":"9","author":"Lee","year":"2002","journal-title":"Cell Death Differ."}],"container-title":["Parasitology International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1383576921000064?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1383576921000064?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,24]],"date-time":"2025-10-24T10:32:58Z","timestamp":1761301978000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1383576921000064"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6]]},"references-count":36,"alternative-id":["S1383576921000064"],"URL":"https:\/\/doi.org\/10.1016\/j.parint.2021.102287","relation":{},"ISSN":["1383-5769"],"issn-type":[{"value":"1383-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2021,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The HIV\u00a0\u2212\u00a01 protease inhibitor Amprenavir targets Leishmania donovani topoisomerase I and induces oxidative stress-mediated programmed cell death","name":"articletitle","label":"Article Title"},{"value":"Parasitology International","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.parint.2021.102287","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"102287"}}